|
|
| Research article summary (published 3 Aug 2009): |
Prophylactic use of the silver-acetate-coated graft in arterial occlusive disease: a retrospective, comparative study.
Full Abstract
OBJECTIVE: Silver-coated vascular polyester prostheses were developed not only for the treatment of prosthetic graft infections, but also for use as prophylaxes. Although some studies describe the use of these prostheses in cases of infection, there are few data on their prophylactic use. This study compares the performance of the InterGard Silver polyester graft (Intervascular, Datascope, Inc, La Ciotat, France) with that of standard prostheses in routine use. METHODS: This retrospective study included all patients who received alloplastic bypass for treatment of arterial occlusive disease at the University Hospital in Würzburg from January 1996 to December 2006. The courses of disease were analyzed by examining the medical records. Follow-up research documented long-term results. RESULTS: The cases of 913 patients were analyzed (430 silver grafts, 483 standard grafts). Indications for the operations were claudication (silver: 136, nonsilver: 212), rest pain (49/65), tissue loss (135/148), and acute occlusion (110/58). Prosthetic implantation was performed in the aorto-iliaco-femoral position (silver: 93, nonsilver: 146), in the femorodistal position (309/304), and as multilevel reconstruction (28/33). With regard to perioperative complications, the two groups did not differ significantly. There were no silver release-related complications, such as colored exudation or wound staining. Mean follow-up time was 56.7 +/- 1.6 (SEM) months. When corrected for redo procedures, stage of disease, and type of reconstruction, both materials performed equally well: 5-year patency for claudication: silver 91%, nonsilver 95%, femorodistal 47%/41%; 5-year patency for critical ischemia: aortofemoral 88%/93%, femorodistal 31%/35%; 5-year limb salvage (critical ischemia): aortofemoral: 78%/79%; femorodistal: 59%/67%. Graft infections (Szilagyi grade III) were detected in 59 patients (6.4%; silver: n = 32, 7.4% vs control: n = 27, 5.5%; P = .28) after an average of 321 +/- 96 days. One infection occurred out of 93 aortofemoral operations with the silver prosthesis (1.1%) compared to 4.1% (6/146) in the control group (P = .17). For patients with femorodistal grafts, silver exhibited an infection rate of 9.4% compared to 5.9% (P = .11). In the multiple regression analysis, two factors influenced the rate of a graft infection significantly: wound healing impairment and revision after bypass implantation. Silver did not prevent a subsequent bypass infection in these cases (silver: 18.1% vs 12.5%, P = .27). CONCLUSION: The silver-coated prosthesis did not differ from standard materials. Silver had no significant effect on the risk of graft infection. Our study showed good results with the silver prosthesis in the aorto-iliaco-femoral position, but in cases of femorodistal grafting, a reduction of prosthetic infections was not achieved. The silver grafts did not prevent subsequent infections in cases of tissue loss or postoperative local complications.
Author information
Author/s: Larena-Avellaneda, Axel (A); Russmann, Sonja (S); Fein, Martin (M); Debus, Eike Sebastian (ES);
Affiliation: Department of Surgery I, University of Würzburg, Medical School, Würzburg, Germany. larena_a(-atsign-)chirurgie.uni-wuerzburg.de
Journal and publication information
Publication Type: Comparative Study; Journal Article
Journal: Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter (J Vasc Surg), published in United States. (Language: eng)
Reference: 2009-Oct; vol 50 (issue 4) : pp 790-8
Dates: Created 2009/09/29; Completed 2009/10/15;
PMID: 19660894, status: MEDLINE (last retrieval date: 10/15/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Meta-analysis of allograft bypass grafting to infrapopliteal arteries.
30 Oct 2004 - Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions.
20 Aug 2006 - Infrainguinal bypass grafting using lyophilized saphenous vein allografts for limb salvage.
30 Jul 2002 - Femoro-femoral arterial bypass is an effective and durable treatment for symptomatic unilateral iliac artery occlusion.
27 Feb 2003 - Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial.
30 Oct 2004 - Conduit choice for above-knee femoropopliteal bypass grafting in patients with limb-threatening ischemia.
14 Jan 2002 - Extensive unilateral iliofemoral occlusions: durability of four techniques of arterial reconstructions.
30 Aug 2004 - Regarding "Adjuvant arteriovenous fistula as a means of rescue for infrapopliteal venous bypass with poor runoff".
29 Apr 2007 - Adjuvant arteriovenous fistula as means of rescue for infrapopliteal venous bypass with poor runoff.
16 Sep 2006 - The distaflo graft: a valid alternative to interposition vein?
27 Feb 2003
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.